Annual Results 2022 - Feb 01, 2023
Webcast and presentation
Annual Report and US Securities & Exchange Commission Form 20-F
These reports, filed with the SIX Swiss Exchange in Switzerland and the US Securities and Exchange Commission (SEC) in the US, provide a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. They also disclose our operating and financial results, accompanied by audited annual financial statements.
To request a hard copy of the Annual Report and/or SEC Form 20-F, fill out the order form.